The Dividing Line Between the Role of the FDA and the Practice of Medicine: A Historical Review and Current Analysis
Show simple item record
| dc.contributor.advisor |
Hutt, Peter Barton
|
en_US |
| dc.contributor.author |
Berry, Carol R. |
en_US |
| dc.date.accessioned |
2012-06-07T05:31:22Z |
|
| dc.date.issued |
1997 |
en_US |
| dc.identifier.citation |
The Dividing Line Between the Role of the FDA and the Practice of Medicine: A Historical Review and Current Analysis (1997 Third Year Paper) |
en |
| dc.identifier.uri |
http://nrs.harvard.edu/urn-3:HUL.InstRepos:8846812 |
|
| dc.description.abstract |
Over the years, the Food and Drug Administration ("FDA") has consistently asserted that it does not regulate the practice of medicine (the "Practice of Medicine Exception") . This prohibition has never been specifically set forth in the statutory scheme which guides the FDA's action. However, the Practice of Medicine Exception has been inferred from the Congressional intent expressed in the legislative history. Although the FDA purports to maintain this exception, the reality is that agency action certainly affects medical practice. |
en |
| dc.language.iso |
en_US |
en |
| dash.license |
LAA |
en_US |
| dc.subject |
Food and Drug Law |
en |
| dc.subject |
doctoral discretion |
en |
| dc.subject |
history of medicine |
en |
| dc.title |
The Dividing Line Between the Role of the FDA and the Practice of Medicine: A Historical Review and Current Analysis |
en |
| dc.type |
Paper (for course/seminar/workshop) |
en_US |
| dc.date.available |
2012-06-07T05:31:22Z |
|
Files in this item
This item appears in the following Collection(s)
Show simple item record
Contact administrator regarding this item (to report mistakes or request changes)